Drug · DIN 02542137
ORGOVYX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 5, 2025; first marketed December 6, 2023.
- Drug Identification Number (DIN)
- 02542137
- Company (DIN owner)
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Relugolix L02BX04
- Class
- Human
- Record last updated
- November 7, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RELUGOLIX | 120 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 5, 2025: NOC 36327New Drug Submission (NDS) · Administrative: Change in product ownership
- October 10, 2023: NOC 31810New Drug Submission (NDS)